Breast-cancer predisposition in multiple endocrine neoplasia type 1
- PMID: 25099597
- PMCID: PMC4243053
- DOI: 10.1056/NEJMc1406028
Breast-cancer predisposition in multiple endocrine neoplasia type 1
References
-
- Thakker RV, Newey PJ, Walls GV, et al. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1) J Clin Endocrinol Metab. 2012;97:2990–3011. - PubMed
-
- Seigne C, Auret M, Treilleux I, et al. High incidence of mammary intraepithelial neoplasia development in Men1-disrupted murine mammary glands. J Pathol. 2013;229:546–58. - PubMed
-
- Imachi H, Murao K, Dobashi H, et al. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance. Breast Cancer Res Treat. 2010;122:395–407. - PubMed
-
- Dreijerink KM, Mulder KW, Winkler GS, Höppener JW, Lips CJ, Timmers HT. Menin links estrogen receptor activation to histone H3K4 trimethylation. Cancer Res. 2006;66:4929–35. - PubMed
-
- de Laat JM, Pieterman CR, Weijmans M, et al. Low accuracy of tumor markers for diagnosing pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 patients. J Clin Endocrinol Metab. 2013;98:4143–51. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical